CoChat

Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial

Xu, Huajun, Zhang, Chujun, Qian, Yingjun, Zou, Jianyin, Li, Xinyi, Liu, Yupu, Zhu, Huaming, Meng, Lili, Liu, Suru, Zhang, Weitian, Yi, Hongliang, Guan, Jian, Chen, Zhengnong, Yin, Shankai · 2020 · Sleep Medicine
Cited by 49

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

BACKGROUND The aim of this study was to determine the efficacy of exogenous melatonin supplementation for sleep disturbances in patients with middle-aged primary insomnia. METHODS This is a randomized double-blind, placebo-controlled parallel study. Participants were recruited from Tianlin community, Xuhui district, Shanghai. Ninety-seven consecutive middle-aged patients with primary insomnia were randomized to receive 3 mg fast-release melatonin (n = 51) or placebo (n = 46) for four-weeks. Objective sleep parameters tested by overnight polysomnography, subjective sleep performance and daytime somnolence obtained from the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI) and Epworth Sleepiness Scale (ESS) were obtained at baseline and after treatment. Treatment was taken daily 1 h before bedtime. Serious adverse events and side-effects were monitored. RESULTS Melatonin supplementation significantly decreased early wake time [-30.63min (95% CI, -53.92 to -7.34); P = 0.001] and percentage of N2 sleep [-7.07% (95% CI, -13.47% to -0.68%); P = 0.031]. However, melatonin had no significant effect on other objective sleep parameters including sleep latency, sleep efficiency, wake during the sleep and percent of N1, N3 and REM sleep. Melatonin had no effect on insomnia symptoms and severity on the PSQI [1.53(95% CI, -0.55 to 3.61); p = 0.504]; ISI [0.81 (95% CI, -2.27 to 3.88); p = 0.165] and ESS [-0.83 (95% CI, -3.53 to 1.88); p = 0.147]. No serious adverse events were reported. CONCLUSIONS Melatonin supplementation over a four-week period is effective and safe in improving some aspects of objective sleep quality such as total sleep time, percentage of rapid eye movement and early morning wake time in middle-aged patients with insomnia. TRIAL REGISTRATION Identifier: ChiCTR-TRC-13003997; Prospectively registered on 2 December 2013.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.sleep.2020.10.018

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 21

  1. Ohayon, 2001, How age and daytime activities are related to insomnia in the general population: consequences for older people, J Am Geriatr Soc, 49, 360, 10.1046/j.1532-5415.2001.49077.x · DOI · Paper page
  2. L, 2016, Prevalence of insomnia and related impact.%A Manjavong M, Med ASJIjopi, 51, 544
  3. Axelrod, 1960, Enzymatic O-methylation of N-acetylserotonin to melatonin, Science, 131, 1312, 10.1126/science.131.3409.1312 · DOI · Paper page
  4. Liu, 1997, Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock, Neuron, 19, 91, 10.1016/S0896-6273(00)80350-5 · DOI · Paper page
  5. Gorfine, 2007, Melatonin and the human hippocampus, a time dependent interplay, J Pineal Res, 43, 80, 10.1111/j.1600-079X.2007.00446.x · DOI · Paper page
  6. M, 2009, Degree of pineal calcification (DOC) is associated with polysomnographic sleep measures in primary insomnia patients, Sleep Med, 10, 439, 10.1016/j.sleep.2008.05.003 · DOI
  7. Haimov, 1994, Sleep disorders and melatonin rhythms in elderly people, BMJ (Clin Res ed), 309, 167, 10.1136/bmj.309.6948.167 · DOI · Paper page
  8. Hajak, 1995, Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia, J Pineal Res, 19, 116, 10.1111/j.1600-079X.1995.tb00179.x · DOI · Paper page
  9. Leger, 2004, Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy, Am J Med, 116, 91, 10.1016/j.amjmed.2003.07.017 · DOI · Paper page
  10. Wade, 2010, Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety, BMC Med, 8, 51, 10.1186/1741-7015-8-51 · DOI · Paper page
  11. Dawson, 1998, Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs, J Biol Rhythm, 13, 532, 10.1177/074873098129000354 · DOI · Paper page
  12. Luthringer, 2009, The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia, Int Clin Psychopharmacol, 24, 239, 10.1097/YIC.0b013e32832e9b08 · DOI · Paper page
  13. Winkler, 2014, Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials, CNS Drugs, 28, 799, 10.1007/s40263-014-0198-7 · DOI
  14. Am, 2003, Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, Crossover Study, 28, 191
  15. Folstein, 1975, "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  16. Buysse, 1989, The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research, Psychiatr Res, 28, 193, 10.1016/0165-1781(89)90047-4 · DOI · Paper page
  17. Wong, 2017, Psychometric properties of the sleep condition indicator and insomnia severity index in the evaluation of insomnia disorder, Sleep Med, 33, 76, 10.1016/j.sleep.2016.05.019 · DOI
  18. Johns, 1992, Reliability and factor analysis of the Epworth sleepiness scale, Sleep, 15, 376, 10.1093/sleep/15.4.376 · DOI · Paper page
  19. Schroeck, 2016, Review of safety and efficacy of sleep medicines in older adults, Clin Therapeut, 38, 2340, 10.1016/j.clinthera.2016.09.010 · DOI · Paper page
  20. Fiorentino, 2010, Awake at 4 AM: treatment of insomnia with early morning awakenings among older adults, J Clin Psychol, 66, 1161, 10.1002/jclp.20734 · DOI
  21. Kay, 2015, Subjective-objective sleep discrepancy among older adults: associations with insomnia diagnosis and insomnia treatment, J Sleep Res, 24, 32, 10.1111/jsr.12220 · DOI · Paper page

Cited by

See all 49

Metadata

Authors
Xu, H., Zhang, C., Qian, Y., Zou, J., Li, X., Liu, Y., Zhu, H., Meng, L., Liu, S., Zhang, W., Yi, H., Guan, J., Chen, Z., & Yin, S.
Venue
Sleep Medicine
Publisher
Elsevier BV
Published
2020-12
Volume
76
Pages
113-119
ISSN
1389-9457 (ISSN-L)
OpenAlex
W3092961942
Cited by
49
References
9
FWCI
4.86
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
Science and Technology Commission of Shanghai Municipality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.